{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T02:27:56Z","timestamp":1773714476210,"version":"3.50.1"},"reference-count":87,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010733","name":"Danish Childhood Cancer Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010733","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.ejmg.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T01:12:19Z","timestamp":1455325939000},"page":"654-660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Treatment-related toxicities in children with acute lymphoblastic leukaemia predisposition syndromes"],"prefix":"10.1016","volume":"59","author":[{"given":"Kjeld","family":"Schmiegelow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmg.2016.02.006_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MOH.0b013e32834114bc","article-title":"Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome","volume":"18","author":"Albert","year":"2011","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ejmg.2016.02.006_bib2","series-title":"Hematology\/the Education Program of the American Society of Hematology American Society of Hematology Education Program","first-page":"29","article-title":"Diagnosis, genetics, and management of inherited bone marrow failure syndromes","author":"Alter","year":"2007"},{"issue":"5","key":"10.1016\/j.ejmg.2016.02.006_bib3","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/leu.2013.363","article-title":"Inherited susceptibility to pre B-ALL caused by germline transmission of PAX5 c. 547G > A","volume":"28","author":"Auer","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmg.2016.02.006_bib4","article-title":"Reduced penetrance of inherited susceptibility to pre B-all caused by germline transmission of Pax5 C.547g > A","volume":"99","author":"Auer","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.ejmg.2016.02.006_bib5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/gcc.20285","article-title":"Population-based study of cancer among carriers of a constitutional structural chromosomal rearrangement","volume":"45","author":"Bache","year":"2006","journal-title":"Gene Chromosome Cancer"},{"issue":"5","key":"10.1016\/j.ejmg.2016.02.006_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ejca.2013.12.005","article-title":"Genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the constitutional mismatch repair deficiency consortium","volume":"50","author":"Bakry","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"23","key":"10.1016\/j.ejmg.2016.02.006_bib7","article-title":"Novel genetic and clinical determinants of constitutional mismatch repair deficiency syndrome: report from the CMMRD consortium","volume":"74","author":"Bakry","year":"2014","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2141.2011.08863.x","article-title":"Promising therapy results for lymphoid malignancies in children with chromosomal breakage syndromes (Ataxia teleangiectasia or Nijmegen-breakage syndrome): a retrospective survey","volume":"155","author":"Bienemann","year":"2011","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejmg.2016.02.006_bib9","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2015.06.013","article-title":"Diagnosis of constitutional mismatch repair-deficiency syndrome based on microsatellite instability and lymphocyte tolerance to methylating agents","volume":"149","author":"Bodo","year":"2015","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/leu.2012.325","article-title":"Physicians compliance during maintenance therapy in children with down syndrome and acute lymphoblastic leukemia","volume":"27","author":"Bohnstedt","year":"2013","journal-title":"Leukemia"},{"issue":"21","key":"10.1016\/j.ejmg.2016.02.006_bib11","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","article-title":"Revisiting Li-Fraumeni syndrome from TP53 mutation carriers","volume":"33","author":"Bougeard","year":"2015","journal-title":"J.\u00a0Clin. Oncol. Official J. Am. Soc. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ejmg.2016.02.006_bib12","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3324\/haematol.2009.019778","article-title":"Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with down syndrome and acute lymphoblastic leukemia","volume":"95","author":"Buitenkamp","year":"2010","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.ejmg.2016.02.006_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1182\/blood-2013-06-509463","article-title":"Acute lymphoblastic leukemia in children with down syndrome: a retrospective analysis from the Ponte di Legno study group","volume":"123","author":"Buitenkamp","year":"2014","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ejmg.2016.02.006_bib14","first-page":"335","article-title":"Acute lymphoidic leukemia in a patient with thrombocytopenia\/absent radii (Tar) syndrome","volume":"15","author":"Camitta","year":"1993","journal-title":"Am. J. Pediatr. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.leu.2400970","article-title":"Profound abnormality of the B\/T lymphocyte ratio during chemotherapy for pediatric acute lymphoblastic leukemia","volume":"12","author":"Caver","year":"1998","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1744-313X.2010.00914.x","article-title":"Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome","volume":"37","author":"Cetiner","year":"2010","journal-title":"Int. J. Immunogenet."},{"issue":"6","key":"10.1016\/j.ejmg.2016.02.006_bib17","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.pcl.2013.09.007","article-title":"The inherited bone marrow failure syndromes","volume":"60","author":"Chirnomas","year":"2013","journal-title":"Pediatr. Clin. N. Am."},{"issue":"11","key":"10.1016\/j.ejmg.2016.02.006_bib18","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/cncr.21040","article-title":"The risk of developing second cancers among survivors of childhood soft tissue sarcoma","volume":"103","author":"Cohen","year":"2005","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.ejmg.2016.02.006_bib19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ejca.2015.02.008","article-title":"Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome","volume":"51","author":"Durno","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"10","key":"10.1016\/j.ejmg.2016.02.006_bib20","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1182\/blood.V87.10.4376.bloodjournal87104376","article-title":"The p53 gene in pediatric therapy-related leukemia and myelodysplasia","volume":"87","author":"Felix","year":"1996","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejca.2013.09.027","article-title":"Complying with the European clinical trials directive while surviving the administrative pressure \u2013 an alternative approach to toxicity registration in a cancer trial","volume":"50","author":"Frandsen","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S0022-3476(87)80131-2","article-title":"Pharmacokinetics and toxicity of methotrexate in children with down-syndrome and acute lymphocytic-leukemia","volume":"111","author":"Garre","year":"1987","journal-title":"J.\u00a0Pediatr US"},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/pbc.23160","article-title":"Congenital pancytopenia and absence of B lymphocytes in a neonate with a mutation in the ikaros gene","volume":"58","author":"Goldman","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.ejmg.2016.02.006_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00043426-199905000-00014","article-title":"Lymphoblastic lymphoma and excessive toxicity from chemotherapy: an unusual presentation for Fanconi anemia","volume":"21","author":"Goldsby","year":"1999","journal-title":"J.\u00a0Pediatr. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.ejmg.2016.02.006_bib25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/bjc.1996.222","article-title":"Occurrence of cancer in women with Turner syndrome","volume":"73","author":"Hasle","year":"1996","journal-title":"Br. J. Cancer"},{"issue":"9199","key":"10.1016\/j.ejmg.2016.02.006_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(99)05264-2","article-title":"Risks of leukaemia and solid tumours in individuals with down's syndrome","volume":"355","author":"Hasle","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejmg.2016.02.006_bib27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00280-009-1184-5","article-title":"DNA incorporation of 6-thioguanine nucleotides during maintenance therapy of childhood acute lymphoblastic leukaemia and non-Hodgkin lymphoma","volume":"66","author":"Hedeland","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmg.2016.02.006_bib28","first-page":"4036","article-title":"Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group","volume":"94","author":"Heerema","year":"1999","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ejmg.2016.02.006_bib29","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.leukres.2004.01.017","article-title":"Familial association of leukemia with colorectal cancer","volume":"28","author":"Hemminki","year":"2004","journal-title":"Leukemia Res."},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MPH.0000000000000151","article-title":"T-cell all in ataxia telangiectasia cured with only 7 Weeks of Anti-leukemic therapy","volume":"37","author":"Hersby","year":"2015","journal-title":"J.\u00a0Pediat Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.ejmg.2016.02.006_bib31","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The genomic landscape of hypodiploid acute lymphoblastic leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib32","first-page":"296","article-title":"Pharmacogenetic and germline prognostic markers of lung cancer","volume":"6","author":"Horgan","year":"2011","journal-title":"J.\u00a0Thorac. Oncol. Official Publ. Int. Assoc. Study Lung Cancer"},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s10875-015-0127-7","article-title":"X-linked agammaglobulinemia associated with B-precursor acute lymphoblastic leukemia","volume":"35","author":"Hoshino","year":"2015","journal-title":"J.\u00a0Clin. Immunol."},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib34","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/pbc.24354","article-title":"The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011","volume":"60","author":"Hunger","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"1\u20132","key":"10.1016\/j.ejmg.2016.02.006_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cancergen.2014.12.003","article-title":"A\u00a0functional variant in miR-605 modifies the age of onset in Li-Fraumeni syndrome","volume":"208","author":"Id Said","year":"2015","journal-title":"Cancer Genet."},{"issue":"1","key":"10.1016\/j.ejmg.2016.02.006_bib36","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood-2013-07-453480","article-title":"How I treat ALL in down's syndrome: pathobiology and management","volume":"123","author":"Izraeli","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ejmg.2016.02.006_bib37","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s12098-015-1733-3","article-title":"Dyskeratosis congenita with acute pre B cell lymphoblastic leukemia in a 10-year-old Girl","volume":"82","author":"Kalasekhar","year":"2015","journal-title":"Indian J. Pediatr."},{"issue":"3","key":"10.1016\/j.ejmg.2016.02.006_bib38","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s10549-015-3424-1","article-title":"TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family","volume":"151","author":"Kappel","year":"2015","journal-title":"Breast Cancer Res. Treat."},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nsmb.2222","article-title":"Regulation of Rev1 by the Fanconi anemia core complex","volume":"19","author":"Kim","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib40","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ajmg.c.30300","article-title":"Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes","volume":"157C","author":"Kratz","year":"2011","journal-title":"Am. J. Med. Genet. C"},{"issue":"8","key":"10.1016\/j.ejmg.2016.02.006_bib41","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/bjc.2015.75","article-title":"Cancer spectrum and frequency among children with Noonan, Costello, and cardio-facio-cutaneous syndromes","volume":"112","author":"Kratz","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"26","key":"10.1016\/j.ejmg.2016.02.006_bib42","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 Blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"New Engl. J. Med."},{"issue":"7496","key":"10.1016\/j.ejmg.2016.02.006_bib43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature13200","article-title":"Domains of genome-wide gene expression dysregulation in down's syndrome","volume":"508","author":"Letourneau","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ejmg.2016.02.006_bib44","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.3324\/haematol.2011.043422","article-title":"Familial myelodysplastic syndromes: a review of the literature","volume":"96","author":"Liew","year":"2011","journal-title":"Haematol Hematol J."},{"issue":"7","key":"10.1016\/j.ejmg.2016.02.006_bib45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood-2014-08-550483","article-title":"How i treat juvenile myelomonocytic leukemia","volume":"125","author":"Locatelli","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejmg.2016.02.006_bib46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/pbc.20018","article-title":"Immunologic monitoring of maintenance therapy for acute lymphoblastic leukaemia in children-preliminary report","volume":"42","author":"Luczynski","year":"2004","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib47","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/pbc.22719","article-title":"Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia","volume":"56","author":"Lund","year":"2011","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.ejmg.2016.02.006_bib48","series-title":"American Society of Clinical Oncology Educational Book\/ASCO American Society of Clinical Oncology Meeting","first-page":"e44","article-title":"Predisposition to pediatric and hematologic cancers: a moving target","author":"Malkin","year":"2014"},{"issue":"7","key":"10.1016\/j.ejmg.2016.02.006_bib49","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/pbc.20843","article-title":"Chemotherapy for myeloid malignancy in children with Fanconi anemia","volume":"48","author":"Mehta","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib50","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00439-009-0715-9","article-title":"Genetic risk factors for melanoma","volume":"126","author":"Meyle","year":"2009","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmg.2016.02.006_bib51","article-title":"Germline aberrations of PAX5 cause susceptibility to pre-B cell acute lymphoblastic leukemia","volume":"36","author":"Miething","year":"2013","journal-title":"Onkologie"},{"issue":"26","key":"10.1016\/j.ejmg.2016.02.006_bib52","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1182\/blood-2014-12-580001","article-title":"Inherited genetic variation in childhood acute lymphoblastic leukemia","volume":"125","author":"Moriyama","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib53","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2006-07-038299","article-title":"Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia","volume":"110","author":"Nachman","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejmg.2016.02.006_bib54","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ng.3253","article-title":"Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia","volume":"47","author":"Noetzli","year":"2015","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.ejmg.2016.02.006_bib55","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/ng.2803","article-title":"Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse","volume":"45","author":"Perez-Andreu","year":"2013","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib56","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1182\/blood-2014-09-595744","article-title":"A\u00a0genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults","volume":"125","author":"Perez-Andreu","year":"2015","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ejmg.2016.02.006_bib57","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.ijrobp.2009.02.057","article-title":"Clinical radiation sensitivity with DNA repair disorders: an overview","volume":"74","author":"Pollard","year":"2009","journal-title":"Int. J. Radiat. Oncol."},{"issue":"7","key":"10.1016\/j.ejmg.2016.02.006_bib58","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/leu.2009.12","article-title":"Induction death and treatment-related mortality in first remission of children with acute lymphoblastic leukemia: a population-based analysis of the Austrian Berlin-Frankfurt-Munster study group","volume":"23","author":"Prucker","year":"2009","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.ejmg.2016.02.006_bib59","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2012-05-378943","article-title":"Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?","volume":"120","author":"Pui","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ejmg.2016.02.006_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2249.2011.04335.x","article-title":"Infections and immunodeficiency in down syndrome","volume":"164","author":"Ram","year":"2011","journal-title":"Clin. Exp. Immunol."},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/pbc.24228","article-title":"Childhood Acute Lymphoblastic Leukemia Collaborative G. Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia","volume":"60","author":"Richards","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"6","key":"10.1016\/j.ejmg.2016.02.006_bib62","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/(SICI)1096-911X(199812)31:6<491::AID-MPO5>3.0.CO;2-B","article-title":"Treatment of lymphoid malignancies in patients with ataxia-telangiectasia","volume":"31","author":"Sandoval","year":"1998","journal-title":"Med. Pediatr. Oncol."},{"issue":"12","key":"10.1016\/j.ejmg.2016.02.006_bib63","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/leu.2008.212","article-title":"Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis","volume":"22","author":"Schmiegelow","year":"2008","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.ejmg.2016.02.006_bib64","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/leu.2011.274","article-title":"High concordance of subtypes of childhood acute lymphoblastic leukemia within families: lessons from sibships with multiple cases of leukemia","volume":"26","author":"Schmiegelow","year":"2012","journal-title":"Leukemia"},{"issue":"19","key":"10.1016\/j.ejmg.2016.02.006_bib65","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1200\/JCO.2012.47.0500","article-title":"Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia","volume":"31","author":"Schmiegelow","year":"2013","journal-title":"J.\u00a0Clin. Oncol. Official J. Am. Soc. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.ejmg.2016.02.006_bib66","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jmedgenet-2011-100674","article-title":"Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms","volume":"49","author":"Schulz","year":"2012","journal-title":"J.\u00a0Med. Genet."},{"issue":"10","key":"10.1016\/j.ejmg.2016.02.006_bib67","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2754","article-title":"A\u00a0recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia","volume":"45","author":"Shah","year":"2013","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ejmg.2016.02.006_bib68","first-page":"508","article-title":"Acute lymphoblastic leukemia with treatment\u2013naive Fanconi anemia","volume":"50","author":"Shah","year":"2013","journal-title":"Indian Pediatr."},{"issue":"1","key":"10.1016\/j.ejmg.2016.02.006_bib69","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40291-013-0020-0","article-title":"Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome: current status of clinical applications and future directions","volume":"17","author":"Sorrell","year":"2013","journal-title":"Mol. Diagn. Ther."},{"key":"10.1016\/j.ejmg.2016.02.006_bib70","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1186\/s12885-015-1549-6","article-title":"Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes","volume":"15","author":"Spinella","year":"2015","journal-title":"BMC Cancer"},{"issue":"5278","key":"10.1016\/j.ejmg.2016.02.006_bib71","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.273.5278.1109","article-title":"Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine","volume":"273","author":"Swann","year":"1996","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.ejmg.2016.02.006_bib72","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.5858\/2009-0015-OA.1","article-title":"Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome","volume":"134","author":"Talwalkar","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"6","key":"10.1016\/j.ejmg.2016.02.006_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005262","article-title":"Germline ETV6 mutations confer susceptibility to acute lymphoblastic leukemia and thrombocytopenia","volume":"11","author":"Topka","year":"2015","journal-title":"PLoS Genet."},{"issue":"9","key":"10.1016\/j.ejmg.2016.02.006_bib74","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/ng.432","article-title":"Germline genomic variants associated with childhood acute lymphoblastic leukemia","volume":"41","author":"Trevino","year":"2009","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.ejmg.2016.02.006_bib75","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00280-015-2717-8","article-title":"Mercaptopurine metabolite levels are predictors of bone marrow toxicity following high-dose methotrexate therapy of childhood acute lymphoblastic leukaemia","volume":"75","author":"Vang","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejmg.2016.02.006_bib76","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1470-2045(11)70119-X","article-title":"Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study","volume":"12","author":"Villani","year":"2011","journal-title":"Lancet Oncol."},{"issue":"16","key":"10.1016\/j.ejmg.2016.02.006_bib77","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood-2011-08-375972","article-title":"Incidence of neoplasia in diamond blackfan anemia: a report from the diamond blackfan anemia registry","volume":"119","author":"Vlachos","year":"2012","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.ejmg.2016.02.006_bib78","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/bi9621573","article-title":"Cytotoxic mechanism of 6-thioguanine: hMutS alpha, the human mismatch binding heterodimer, binds to DNA containing S-6-methylthioguanine","volume":"36","author":"Waters","year":"1997","journal-title":"Biochem. Us"},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib79","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00062752-200003000-00003","article-title":"Diamond-Blackfan anemia","volume":"7","author":"Willig","year":"2000","journal-title":"Curr. Opin. Hematol."},{"issue":"5","key":"10.1016\/j.ejmg.2016.02.006_bib80","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3324\/haematol.2009.021626","article-title":"Constitutional mismatch repair-deficiency syndrome","volume":"95","author":"Wimmer","year":"2010","journal-title":"Haematol Hematol J."},{"issue":"6","key":"10.1016\/j.ejmg.2016.02.006_bib81","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/jmedgenet-2014-102284","article-title":"Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium 'care for CMMRD' (C4CMMRD)","volume":"51","author":"Wimmer","year":"2014","journal-title":"J.\u00a0Med. Genet."},{"issue":"8","key":"10.1016\/j.ejmg.2016.02.006_bib82","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S1470-2045(14)70294-3","article-title":"How safe is a standard-risk child with ALL?","volume":"15","author":"Winther","year":"2014","journal-title":"Lancet Oncol."},{"issue":"9283","key":"10.1016\/j.ejmg.2016.02.006_bib83","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0140-6736(01)05838-X","article-title":"Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study","volume":"358","author":"Winther","year":"2001","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib84","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.3747\/co.21.1841","article-title":"Lack of toxicity in a patient with germline TP53 mutation treated with radiotherapy","volume":"21","author":"Wong","year":"2014","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.ejmg.2016.02.006_bib85","doi-asserted-by":"crossref","first-page":"7553","DOI":"10.1038\/ncomms8553","article-title":"Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children","volume":"6","author":"Xu","year":"2015","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ejmg.2016.02.006_bib86","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/ng.3177","article-title":"Germ line ETV6 mutations in familial thrombocytopenia and hematologic malignancy","volume":"47","author":"Zhang","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2016.02.006_bib87","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1508054","article-title":"Germline mutations in predisposition genes in pediatric Cancer","author":"Zhang","year":"2015","journal-title":"N.\u00a0Engl. J. Med."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721216300246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721216300246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:44:06Z","timestamp":1761709446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721216300246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":87,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1769721216300246"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2016.02.006","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment-related toxicities in children with acute lymphoblastic leukaemia predisposition syndromes","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}